We are live on ! Find out more
ROIV icon

Roivant Sciences

42 hedge funds and large institutions have $3.42B invested in Roivant Sciences in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49.54% more ownership

Funds ownership: 0%49.54% (+50%)

Holders
42
Holders Change
+42
Holders Change %
% of All Funds
0.65%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.11%
New
42
Increased
Reduced
Closed
Calls
$504K
Puts
Net Calls
+$504K
Net Calls Change
+$504K

ROIV Hedge Fund Activity: Q4 2021 in Review

42 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q4 2021, worth a combined $3.42B.

Buyers outnumbered sellers: 42 funds opened new ROIV positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $1.08B.

  • 42 institutional investors held Roivant Sciences (ROIV) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $3.42B of Roivant Sciences stock for Q4 2021.
  • 42 funds opened new Roivant Sciences positions in Q4 2021 and 0 closed out, a net change of +42 holders.
  • The largest Roivant Sciences buyer in Q4 2021 was QVT Financial, an estimated $1.08B added.

Based on aggregated 13F filings for Q4 2021.